Survey of CDC-recognized community pharmacies providing the National Diabetes Prevention Program and impact of the COVID-19 pandemic on program delivery.
Survey of CDC-recognized community pharmacies providing the National Diabetes Prevention Program and impact of the COVID-19 pandemic on program delivery.
复制标题
DOI：
10.1016/j.japh.2022.03.020
复制
发表时间：
2022-09
期刊：
影响因子：
--
通讯作者：
Dixon DL
中科院分区：
文献类型：
--
作者：
Spence R;Sisson EM;Dixon DL
疾病控制和预防中心（CDC）建立了国家糖尿病预防计划（NDPP），以预防2型糖尿病，使用社区和卫生保健组织（包括社区药房）提供的循证生活方式干预计划。这项研究旨在描述CDC认可的社区药房提供NDPP，并确定2019冠状病毒病（COVID-19）大流行对计划交付的影响。CDC认可的社区药房提供NDPP的名单于2020年9月19日从CDC认可计划登记处获得。创建了一个23个问题的横断面调查，以获取有关计划启动、交付、招聘、注册、计划评估、报销和COVID-19大流行影响的信息。通过电话使用标准化脚本联系每个药房，并邀请他们通过电话或在线完成调查。大约2周后，向未回复的药房发送了一封后续电子邮件。CDC登记处共确定了73家社区药店。在64家符合条件的社区药店中，42%（n = 27）完成了调查。大多数提供NDPP的社区药房位于美国东南部（41%）和中西部（22%）地区。大多数是独立药店（78%），并有“悬而未决”的疾病预防控制中心的认可状态（74%）。计划交付主要发生在药房（48%）或混合模式（26%）。大多数项目没有提交报销申请（74%），也没有向参与者收取费用（82%）。近三分之二的药店（63%）强烈同意COVID-19严重影响了他们的计划，但大多数药店（67%）在疫情期间继续提供NDPP。据我们所知，这是CDC认可的社区药房提供NDPP的第一个特征。在社区药店实施NDPP的最佳做法值得进一步探索和模式，以确保长期可持续性。COVID-19影响了大多数提供NDPP的社区药房，但大多数药房在大流行期间继续提供NDPP。
The Centers for Disease Control and Prevention (CDC) established the National Diabetes Prevention Program (NDPP) to prevent type 2 diabetes using an evidence-based lifestyle intervention program provided by community- and health care–based organizations, including community pharmacies. This study aimed to characterize CDC-recognized community pharmacies offering NDPP and determine the impact of the coronavirus disease 2019 (COVID-19) pandemic on program delivery. A list of CDC-recognized community pharmacies offering NDPP was obtained from the CDC Registry of Recognized Programs on September 19, 2020. A 23-question cross-sectional survey was created to obtain information about program inception, delivery, recruitment, enrollment, program evaluation, reimbursement, and the impact of the COVID-19 pandemic. Each pharmacy was contacted via telephone using a standardized script and invited to complete the survey over the phone or online. A follow-up e-mail was then sent approximately 2 weeks later to pharmacies that had not responded. A total of 73 community pharmacies were identified in the CDC registry. Of the 64 eligible community pharmacies, 42% (n = 27) completed the survey. Most community pharmacies offering NDPP were in the Southeastern (41%) and Midwestern (22%) regions of the United States. A majority were independent pharmacies (78%) and had “pending” CDC recognition status (74%). Program delivery primarily occurred in the pharmacy (48%) or in a hybrid model (26%). Most programs were not submitting reimbursement claims (74%) and did not charge participants (82%). Nearly two-thirds of pharmacies (63%) strongly agreed that COVID-19 had significantly affected their programs, yet most (67%) continued to offer NDPP during the pandemic. To our knowledge, this is the first characterization of CDC-recognized community pharmacies providing NDPP. Best practices for implementing NDPP at community pharmacies warrant further exploration and models to ensure long-term sustainability. COVID-19 affected most community pharmacies providing NDPP, but the majority continued to offer NDPP during the pandemic.
登录
查看更多内容
DOI：
10.18549/pharmpract.2021.2.2426
发表时间：
2021-04
期刊：
Pharmacy practice
影响因子：
--
作者：
Dixon DL;Sisson EM;Pamulapati LG;Spence R;Salgado TM
通讯作者：
Salgado TM
DOI：
10.1136/bmj.i5953
发表时间：
2016-11-23
期刊：
BMJ (Clinical research ed.)
影响因子：
--
作者：
Huang Y;Cai X;Mai W;Li M;Hu Y
通讯作者：
Hu Y
影响因子：
158.5
作者：
Knowler, WC;Barrett-Connor, E;Nathan, DM
通讯作者：
Nathan, DM
影响因子：
13.8
作者：
Ali, Mohammed K.;Bullard, Kai McKeever;Gregg, Edward W.
通讯作者：
Gregg, Edward W.
影响因子：
5.7
作者：
Moin, Tannaz;Duru, O. Kenrik;Mangione, Carol M.
通讯作者：
Mangione, Carol M.